Ilyang to present positive preclinical results of new influenza antiviral drug

Published: 2012-05-17 06:56:00

Updated: 2012-05-17 06:56:00

Ilyang Pharmaceutical Co. said Tuesday that it will announce positive data from preclinical study of its new influenza antiviral drug at the 31st Annual Meeting to be hosted by the American Society for Virology and held at the University of Wisconsin-Madison between July 21 and 25, 2012.

The p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK